Identification of HLA-CW3, GNAS and IMPA as Cytotoxic T-Lymphocyte (CTL) Target Antigens Using an Allogeneic Mixed Lymphocyte Tumor Cell Culture (MLTC) System and Subsequent cDNA Library Screening-Reference-Cited by-同舟云学术

Identification of HLA-CW3, GNAS and IMPA as Cytotoxic T-Lymphocyte (CTL) Target Antigens Using an Allogeneic Mixed Lymphocyte Tumor Cell Culture (MLTC) System and Subsequent cDNA Library Screening

Published:2007-04 Issue:2 Volume:22 Page:206-222
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Wroblewski Joanne M.¹,Yannelli John R.²

Affiliation:

1. Division of Endocrinology, Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, KY

2. Department of Microbiology/Immunology and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2007.341

Reference68 articles.

1. A listing of human tumor antigens recognized by T cells: March 2004 update

2. Identification of tumor antigens and T-cell epitopes, and its clinical application

3. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

4. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of prognostic coagulation-related signatures in clear cell renal cell carcinoma through integrated multi-omics analysis and machine learning;Computers in Biology and Medicine;2024-01

2. Cellular immunotherapy (CI), where have we been and where are we going?;Principles of Cancer Biotherapy;2009